Bosentan in Digital Ulcers

NCT00319696 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Digital Ulcers

Interventions

DRUG: Bosentan 62.5 mg
DRUG: Bosentan 125 mg

Sponsor

Actelion